Loading...
PhD Maja Čemažar

PhD Maja Čemažar
no.: 14575 source: ARIS

researcher – active in research organisation
Phone number (01) 587 95 44
E-mail mcemazarat signonko-i.si
Foreign language skills
Research activity

Code Science Field Subfield
3.04.00  Medical sciences  Oncology   
3.01.00  Medical sciences  Microbiology and immunology   
Keywords
Experimental oncology, electroporotion, chemotherapy, radiobiology, electrochemotherapy
Points
2,473.71
A''
71.16
A'
960.42
A1/2
1,381.57
CI10
6,169
CImax
465
h10
40
A1
6.61
A3
10
Data for the last 5 years (citations for the last 10 years) on September 30, 2023; A3 for period 2017-2021 (update for tender in 2022: YES)
Data for ARIS tenders ( 14.06.2023 – Target research programmes, archive )
Database Linked records Citations Pure citations Average pure citations
WoS 317  9,724  6,736  21.25 
Scopus 330  11,584  8,212  24.88 
Mentoring junior researchers
source: ARIS
no. Name and surname Type Period Code
1 Ajda Medved  Bologna doctoral studies    55824 
2 PhD Barbara Lisec  Bologna doctoral studies  10/1/2016 - 1/13/2022  39122 
3 PhD Katarina Žnidar  Bologna doctoral studies  11/1/2014 - 10/18/2019  37534 
4 PhD Urša Lampreht Tratar  Bologna doctoral studies  10/1/2013 - 8/21/2018  36367 
5 PhD Andreja Brožič  Bologna doctoral studies  12/1/2012 - 7/13/2016  35354 
6 PhD Nataša Tešić  Bologna doctoral studies  11/1/2011 - 5/4/2015  34477 
7 PhD Boštjan Markelc  Bologna doctoral studies  10/1/2009 - 3/31/2013  32175 
8 PhD Vesna Todorović  Uniform doctoral studies  10/1/2007 - 3/31/2011  29469 
9 PhD Gregor Tevž  Uniform doctoral studies  11/1/2005 - 4/30/2009  26164 
Education
source: ARIS
Level of education Professional title Study subject Faculty Year
Bachelor's degree  B. Sc.     SI University of Ljubljana, Biotechnical Faculty 1992 
Master's degree  M. Sc.     SI University of Ljubljana, Faculty of Medicine 1996 
Doctor's degree  Ph. D.     SI University of Ljubljana, Faculty of Medicine 1998 
Doctoral dissertations and other final papers Show
Obtaining results now
source: COBISS
Employments
source: ARIS
Type of employment Research org. Research group Date of employment Position Title
Full time employment (60%, RD:60%)  Institute of Oncology Ljubljana  Department of research  11/1/1992  Research counsellor   
Full time employment (60%, RD:30%)  Universita del Litorale, Facolta di Scienze della Salute  Raziskovalna skupina UP FVZ (Slovene)  9/19/2005  Professor   
Research projects Legend
source: ARIS
no. Code Title Period Head No. of publications
1. J7-4540  Družbeno-ekonomske posledice rakavih obolenj z vidika posameznika in družbe ter analiza vpliva pandemije covid-19 (Slovene)   2022 - 2023  PhD Ivica Ratoša  4,438 
2. J7-4635  MitoCan - Predklinični razvoj novih zaviralcev mitohondrijskih ionskih kanalov za zdravljenje raka (Slovene)   2022 - 2023  PhD Lucija Peterlin Mašič  5,812 
3. L7-4491  Razvoj integriranega mnogo kanalnega umetnega nosu za detekcijo raka (Slovene)   2022 - 2023  PhD Igor Muševič  5,256 
4. J1-4417  Razvoj novih nizkomolekularnih modulatorjev Tollu podobnih receptorjev 7 in 8 za imunoterapijo raka (Slovene)   2022 - 2023  PhD Matej Sova  3,777 
5. J3-4504  Z vizualizacijo mikrookolja glioblastoma do boljše terapije (Slovene)   2022 - 2023  PhD Metka Novak  1,684 
6. J3-3084  Inducible Programming of CAR T Cell Intrinsic Properties for Cancer Immunotherapy   2021 - 2023  PhD Anže Smole  2,387 
7. J3-3083  Vascularization and vascular effects as predictive factors for local ablative techniques   2021 - 2023  PhD Gregor Serša  6,536 
8. J3-2528  Immuno gene electrotransfer of IL-12 and IL-2 in immunologically cold/hot tumors   2020 - 2023  PhD Maja Čemažar  3,051 
9. J4-2546  Monitoring of the clinical and immune response to improve the outcome of combined electrochemotherapy and IL-12 gene therapy in dogs with spontaneous peripheral tumours   2020 - 2023  PhD Nataša Tozon  3,426 
10. J3-2529  Role of endothelium in tumor response to radiotherapy   2020 - 2023  PhD Boštjan Markelc  3,211 
11. J7-2594  The amniotic membrane as a novel multimodal therapy for bacterial cystitis and bladder cancer: unravelling its antimicrobial, immunomodulatory and anticancer activity   2020 - 2023  PhD Mateja Erdani Kreft  4,977 
12. J3-9269  Clinico-pharmacological approach to optimize the therapeutic bleomycin concentration in patients undergoing electrochemotherapy   2018 - 2021  PhD Gregor Serša  3,332 
13. N3-0059  Plasma-assisted wound treatment and topical introduction of molecules   2017 - 2020  PhD Uroš Cvelbar  2,930 
14. J4-8227  Cathepsin X inhibitors impair the resistence of tumor cells to antiprotease therapy   2017 - 2020  PhD Janko Kos  4,412 
15. J3-8202  Time-lapse intra-vital imaging of immune response after electrochemotherapy induced in situ vaccination and Interleukin-12 gene therapy boost   2017 - 2020  PhD Maja Čemažar  3,400 
16. L2-7550  Elecrospun nanofibrous materials for solid state drug delivery system   2016 - 2019  PhD Igor Emri  4,307 
17. J3-7460  Irradiation dose modifying factor of squamous cell carcinoma of the oropharynx infected by human papillomavirus: an in vitro and in vivo study in laboratory mouse tumor model   2016 - 2018  PhD Primož Strojan  4,122 
18. J3-7494  Tunneling nanotubes for innovative urinary bladder cancer treatments   2016 - 2018  PhD Mateja Erdani Kreft  6,869 
19. J1-6730  Development of new hepatic cell lines for genotoxicity and carcinogenicity studies: new hope for human health and laboratory animal welfare protection   2014 - 2017  PhD Metka Filipič  3,912 
20. J1-6744  Development of Molecularly Imprinted Polymers and their application in environmental and bio-analysis   2014 - 2017  PhD Tina Kosjek  4,659 
21. J1-6734  Lightweight alloys based on aluminium as materials with increasing potential in transport industry   2014 - 2017  PhD Ingrid Milošev  3,375 
22. J3-6793  New approaches of tumor radiosenzibilization with gene therapy   2014 - 2017  PhD Gregor Serša  4,921 
23. J3-6796  Translational oncology: development and validtion of immunogene therapy with Interleukin-12 combined with surgery for canine cancers of the oral cavity and skin   2014 - 2017  PhD Maja Čemažar  4,539 
24. J3-5505  Electrochemotherapy in treatment of deep seated tumors   2013 - 2016  PhD Gregor Serša  4,128 
25. J4-5529  Nitroxoline and its derivatives as new antitumour drugs   2013 - 2016  PhD Janko Kos  5,759 
26. J3-4211  Antiangiogenic gene therapy of cancer using electroporation and magnetic nanoparticles as targeted delivery systems   2011 - 2014  PhD Gregor Serša  6,271 
27. J1-4044  Apoptotic effects of alkylpyridinium compounds on lung adenocarcinoma cells   2011 - 2014  PhD Tom Turk  6,075 
28. L2-4105  Development and validation of a software for numerical modeling of in vivo electroporation - in silico electroporation   2011 - 2014  PhD Damijan Miklavčič  4,657 
29. J3-4259  Preparation and validation of therapeutic plasmids without selection gene for antibiotic resistance for cancer gene therapy using inducible and tissue-specific promoters   2011 - 2014  PhD Maja Čemažar  5,657 
30. J1-4131  Synthesis, characterisation and use of novel ruthenium compounds in electrochemotherapy of tumors   2011 - 2014  PhD Iztok Turel  5,718 
31. J2-3639  New lipid model systems for determination of electroporation basic mechanisms   2010 - 2013  PhD Damijan Miklavčič  4,954 
32. J3-2277  Kombinacija elektrogenske imunske terapije z interlevkinom-12 in obsevanjem za zdravljenje eksperimentalnih tumorjev (Slovene)   2009 - 2012  PhD Maja Čemažar  2,748 
33. J3-2218  Ugotavljanje infekcije protez pri zamenjavi umetnih sklepov (Slovene)   2009 - 2012  PhD Andrej Cör  2,793 
34. J3-0485  Antiangiogenic siRNA for the treatment of advanced malignant melanoma   2008 - 2011  PhD Maja Čemažar  2,511 
35. J3-9580  Development of cell biosensor systems for determination of effects of ionizing radiation and chemical carcinogens   2007 - 2009  PhD Gregor Serša  2,392 
36. J7-9743  The impact of health care on the quality of life of elderly people: The influence of incontinence and impaired mobility on functionary of elderly people   2007 - 2009  PhD Maja Čemažar  2,866 
37. M1-0151  Molekularna detekcija posledic uporabe in delovanja biološkega orožja in toksinov z dolgodobnim delovanjem (Slovene)   2007 - 2008  PhD Metka Filipič  5,014 
38. J3-7044  Treatment of malignant tumours with electrogene therapy   2005 - 2008  PhD Maja Čemažar  3,277 
39. J3-6260  Vpliv infuzij nizkih odmerkov citostatikov na tumorske celice in pretok krvi v tumorjih (Slovene)   2004 - 2007  PhD Marija Auersperg  4,225 
40. L3-5012  MOLEKULAR GENETIC PREDISPOSITION FOR DEVELOPMENT OF SOME CANCERS   2003 - 2005  PhD Metka Ravnik-Glavač  4,535 
41. J3-4207  Ocena učinkovitosti presejanja za raka materničnega vratu v Sloveniji; študija primerov s kontrolami (Slovene)   2002 - 2005  PhD Maja Primic-Žakelj  3,119 
42. J3-4176  Predklinične raziskave elektrogenske terapije v onkologiji (Slovene)   2002 - 2005  PhD Maja Čemažar  4,729 
43. J3-3489  New biomedical applications of electroporation   2002 - 2004  PhD Gregor Serša  3,957 
44. J3-2049  Uporaba elektroporacij v genski terapiji (Slovene)   2000 - 2002  PhD Maja Čemažar  4,017 
45. J3-7843  Elektrokemoterapija - nov pristop k zdravljenju raka (Slovene)   1996 - 2001  PhD Gregor Serša  4,047 
ARIS research and infrastructure programmes Legend
source: ARIS
no. Code Title Period Head No. of publications
1. P3-0003  Development and evaluation of new approaches to cancer treatment   2022 - 2023  PhD Gregor Serša  3,767 
2. P3-0003  Development and evaluation of new approaches to cancer treatment   2015 - 2021  PhD Gregor Serša  3,140 
3. P3-0003  Development and evaluation of new approaches to cancer treatment   2009 - 2014  PhD Gregor Serša  3,896 
4. P3-0003  Development and evaluation of new approaches to cancer treatment   2004 - 2008  PhD Gregor Serša  2,982 
International projects
no. Code Title Period Head No. of publications
1. COST-TD1104  COST - European Network for Development of Electroporation-based technologies and treatments EP4Bio2Med   4/10/2012 - 4/9/2016  Damijan Miklavčič   
Views history
Favourite